← Leaderboards
Israel F. Charo
J. David Gladstone Institutes
$11,507,849
Attributed
$11,507,849
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$11,507,849 · 4
By mechanism
R01$11,497,849 · 3
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Most similar at J. David Gladstone Institutes
Same institution · by research overlap
- Tony Wyss-Coray$32,197,912
- Douglas F Nixon$54,453,314
- Mark A Goldsmith$2,490,083
- Eric M Verdin$53,862,857
- Wendy Peters$677,519
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisChemokineLaboratory MouseMacrophageGenetically Modified AnimalsReceptor BindingProtein Structure FunctionCytokine ReceptorsIntegrinsChemokine ReceptorKnock-In MouseCellsMediatingCx3cl1 GeneMonocyteApolipoprotein ETraffickingBloodIn VivoCell SurfaceBone Marrow CellsFundingBone MarrowBlood Circulation
Grant awards (24)
CCR2 in Hematopoietic Stem Cell Homing, Macrophage Polarization and Organ Repair$467,950
R01 · FY2014 · HL · contact PI
CCR2 in Hematopoietic Stem Cell Homing, Macrophage Polarization and Organ Repair$454,580
R01 · FY2013 · HL · contact PI
CCR2 in Hematopoietic Stem Cell Homing, Macrophage Polarization and Organ Repair$477,500
R01 · FY2012 · HL · contact PI
CCR2 in Hematopoietic Stem Cell Homing, Macrophage Polarization and Organ Repair$477,500
R01 · FY2011 · HL · contact PI
CCR2 in Atherosclerosis and Monocyte Trafficking$618,558
R01 · FY2010 · HL · contact PI
CCR2 in Atherosclerosis and Monocyte Trafficking$618,263
R01 · FY2009 · HL · contact PI
CCR2 in Atherosclerosis and Monocyte Trafficking$603,936
R01 · FY2008 · HL · contact PI
CCR2 in Atherosclerosis and Monocyte Trafficking$598,311
R01 · FY2007 · HL · contact PI
Fractalkine: Roles in Cell Adhesion and Atherosclerosis$550,280
R01 · FY2007 · HL · contact PI
CCR2 in Atherosclerosis and Leukocyte Trafficking$571,949
R01 · FY2006 · HL · contact PI
Fractalkine: Roles in Cell Adhesion and Atherosclerosis$563,059
R01 · FY2006 · HL · contact PI
Fractalkine: Roles in Cell Adhesion and Atherosclerosis$578,552
R01 · FY2005 · HL
CCR2 in Atherosclerosis and Leukocyte Trafficking$554,696
R01 · FY2005 · HL
2005 Atherosclerosis Gordon Conference$10,000
R13 · FY2005 · HL
Fractalkine: Roles in Cell Adhesion and Atherosclerosis$447,500
R01 · FY2004 · HL
CCR2 in Atherosclerosis and Leukocyte Trafficking$447,500
R01 · FY2004 · HL
FRACTALKINE: ROLES IN CELL ADHESION AND ATHEROSCLEROSIS$456,232
R01 · FY2003 · HL
CCR2 in Atherosclerosis and Leukocyte Trafficking$447,500
R01 · FY2003 · HL
FRACTALKINE: ROLES IN CELL ADHESION AND ATHEROSCLEROSIS$445,234
R01 · FY2002 · HL
CCR2 AND CCR5--ATHEROSCLEROSIS AND CONTROL OF EXPRESSION$419,821
R01 · FY2002 · HL
FRACTALKINE: ROLES IN CELL ADHESION AND ATHEROSCLEROSIS$434,557
R01 · FY2001 · HL
CCR2 AND CCR5--ATHEROSCLEROSIS AND CONTROL OF EXPRESSION$410,186
R01 · FY2001 · HL
FRACTALKINE: ROLES IN CELL ADHESION AND ATHEROSCLEROSIS$453,353
R01 · FY2000 · HL
CCR2 AND CCR5--ATHEROSCLEROSIS AND CONTROL OF EXPRESSION$400,832
R01 · FY2000 · HL